• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

验证 SPARCC MRI-RETIC e 工具在提高 MRI 骶髂关节病变在中轴型脊柱关节炎的评分准确性中的作用。

Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis.

机构信息

Medicine, University of Alberta, Edmonton, Alberta, Canada

CARE ARTHRITIS Limited, Edmonton, Alberta, Canada.

出版信息

RMD Open. 2024 Feb 13;10(1):e003923. doi: 10.1136/rmdopen-2023-003923.

DOI:10.1136/rmdopen-2023-003923
PMID:38351052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10868186/
Abstract

BACKGROUND

The Spondyloarthritis Research Consortium of Canada (SPARCC) developers have created web-based calibration modules for the SPARCC MRI sacroiliac joint (SIJ) scoring methods. We aimed to test the impact of applying these e-modules on the feasibility and reliability of these methods.

METHODS

The SPARCC-SIJ e-modules contain cases with baseline and follow-up scans and an online scoring interface. Visual real-time feedback regarding concordance/discordance of scoring with expert readers is provided by a colour-coding scheme. Reliability is assessed in real time by intraclass correlation coefficient (ICC), cases being scored until ICC targets are attained. Participating readers (n=17) from the EuroSpA Imaging project were randomised to one of two reader calibration strategies that each comprised three stages. Baseline and follow-up scans from 25 cases were scored after each stage was completed. Reliability was compared with a SPARCC developer, and the System Usability Scale (SUS) assessed feasibility.

RESULTS

The reliability of readers for scoring bone marrow oedema was high after the first stage of calibration, and only minor improvement was noted following the use of the inflammation module. Greater enhancement of reader reliability was evident after the use of the structural module and was most consistently evident for the scoring of erosion (ICC status/change: stage 1 (0.42/0.20) to stage 3 (0.50/0.38)) and backfill (ICC status/change: stage 1 (0.51/0.19) to stage 3 (0.69/0.41)). The feasibility of both e-modules was evident by high SUS scores.

CONCLUSION

The SPARCC-SIJ e-modules are feasible, effective knowledge transfer tools, and their use is recommended before using the SPARCC methods for clinical research and tria.

摘要

背景

加拿大脊柱关节炎研究联合会（SPARCC）开发者创建了基于网络的 SPARCC MRI 骶髂关节（SIJ）评分方法校准模块。我们旨在测试应用这些电子模块对这些方法的可行性和可靠性的影响。

方法

SPARCC-SIJ 电子模块包含基线和随访扫描病例，以及在线评分界面。通过颜色编码方案提供有关与专家读者评分一致性/不一致性的实时视觉反馈。通过组内相关系数（ICC）实时评估可靠性，评分直至达到 ICC 目标。来自 EuroSpA Imaging 项目的参与读者（n=17）随机分为两种读者校准策略之一，每种策略均包含三个阶段。在完成每个阶段后，对 25 例基线和随访扫描进行评分。与 SPARCC 开发者进行可靠性比较，并使用系统可用性量表（SUS）评估可行性。

结果

在第一阶段校准后，读者对骨髓水肿评分的可靠性很高，在使用炎症模块后仅略有提高。使用结构模块后，读者的可靠性得到了更大的提高，并且在评分侵蚀（ICC 状态/变化：第 1 阶段（0.42/0.20）至第 3 阶段（0.50/0.38））和填充（ICC 状态/变化：第 1 阶段（0.51/0.19）至第 3 阶段（0.69/0.41））方面最为明显。两个电子模块的可行性都通过高 SUS 得分得到证明。

结论

SPARCC-SIJ 电子模块是可行的、有效的知识转移工具，建议在将 SPARCC 方法用于临床研究和试验之前使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/e4e2c9fb8844/rmdopen-2023-003923f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/7b7ec2024767/rmdopen-2023-003923f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/f8115089af8e/rmdopen-2023-003923f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/d7328bb8093c/rmdopen-2023-003923f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/abd4df6e70d2/rmdopen-2023-003923f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/8c986bbacece/rmdopen-2023-003923f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/e4e2c9fb8844/rmdopen-2023-003923f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/7b7ec2024767/rmdopen-2023-003923f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/f8115089af8e/rmdopen-2023-003923f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/d7328bb8093c/rmdopen-2023-003923f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/abd4df6e70d2/rmdopen-2023-003923f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/8c986bbacece/rmdopen-2023-003923f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d500/10868186/e4e2c9fb8844/rmdopen-2023-003923f06.jpg

相似文献

1
Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis.验证 SPARCC MRI-RETIC e 工具在提高 MRI 骶髂关节病变在中轴型脊柱关节炎的评分准确性中的作用。
RMD Open. 2024 Feb 13;10(1):e003923. doi: 10.1136/rmdopen-2023-003923.
2
Spondyloarthritis Research Consortium of Canada sacroiliac joint inflammation and structural scores: change score reliability and recalibration utility in children.加拿大脊柱关节炎研究联合会骶髂关节炎症和结构评分：儿童变化评分可靠性和再校准效用。
Arthritis Res Ther. 2020 Mar 24;22(1):58. doi: 10.1186/s13075-020-02157-4.
3
Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score.加拿大脊柱关节炎研究联盟磁共振成像骶髂关节结构评分的开发与初步验证
J Rheumatol. 2015 Jan;42(1):79-86. doi: 10.3899/jrheum.140519. Epub 2014 Oct 15.
4
Development and Validation of MRI Sacroiliac Joint Scoring Methods for the Semiaxial Scan Plane Corresponding to the Berlin and SPARCC MRI Scoring Methods, and of a New Global MRI Sacroiliac Joint Method.半轴向扫描平面对应柏林和 SPARCC MRI 评分方法的 MRI 骶髂关节评分方法的开发和验证，以及一种新的全局 MRI 骶髂关节方法。
J Rheumatol. 2018 Jan;45(1):70-77. doi: 10.3899/jrheum.161583. Epub 2017 Oct 1.
5
Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.使用加拿大脊柱关节炎研究联合会评分系统评估中轴型脊柱关节炎的骶髂关节炎的活动性炎症、慢性结构损伤和治疗反应。
BMC Musculoskelet Disord. 2022 Jul 8;23(1):654. doi: 10.1186/s12891-022-05609-x.
6
Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.在EMBARK试验中，依那西普对骶髂关节MRI结构损伤的改善：一项针对非放射学中轴型脊柱关节炎患者的12周随机安慰剂对照试验。
Ann Rheum Dis. 2018 Jan;77(1):78-84. doi: 10.1136/annrheumdis-2017-211605. Epub 2017 Sep 29.
7
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.通过磁共振成像对强直性脊柱炎脊柱炎症活动进行评分：一项多阅片者实验
J Rheumatol. 2007 Apr;34(4):862-70.
8
Spondyloarthritis Research Consortium of Canada Scoring System for Sacroiliitis in Juvenile Spondyloarthritis/Enthesitis-related Arthritis: A Reliability, Validity, and Responsiveness Study.加拿大脊柱关节炎研究联合会幼年特发性脊柱关节炎/附着点炎相关关节炎的骶髂关节炎评分系统：一项可靠性、有效性和反应性研究。
J Rheumatol. 2019 Jun;46(6):636-644. doi: 10.3899/jrheum.180222. Epub 2019 Feb 1.
9
Can radiomics replace the SPARCC scoring system in evaluating bone marrow edema of sacroiliac joints in patients with axial spondyloarthritis?放射组学能否取代 SPARCC 评分系统评估中轴型脊柱关节炎患者骶髂关节骨髓水肿？
Clin Rheumatol. 2023 Jun;42(6):1675-1682. doi: 10.1007/s10067-023-06543-6. Epub 2023 Feb 16.
10
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.通过磁共振成像对骶髂关节进行评分。一项多阅片者可靠性实验。
J Rheumatol. 2005 Oct;32(10):2050-5.

引用本文的文献

1
Time-efficient MRI scoring system for axial spondyloarthritis: a feasibility study.用于轴性脊柱关节炎的高效MRI评分系统：一项可行性研究。
Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11855-z.

本文引用的文献

1
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.依奇珠单抗治疗对非放射性轴性脊柱关节炎患者骶髂关节结构改变的影响：16 周时的 MRI 评估。
Lancet Rheumatol. 2022 Sep;4(9):e626-e634. doi: 10.1016/S2665-9913(22)00185-0. Epub 2022 Aug 9.
2
Instrument selection for the ASAS core outcome set for axial spondyloarthritis.用于评估中轴型脊柱关节炎的 ASAS 核心结局集的工具选择。
Ann Rheum Dis. 2023 Jun;82(6):763-772. doi: 10.1136/annrheumdis-2022-222747. Epub 2022 Jun 9.
3
Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging.
改善领域定义和结局评估工具选择：影像学为 OMERACT 提供的经验教训。
Semin Arthritis Rheum. 2021 Oct;51(5):1125-1133. doi: 10.1016/j.semarthrit.2021.08.004. Epub 2021 Aug 20.
4
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).在活动性强直性脊柱炎患者中，12 周时 fingolimod 对骶髂关节磁共振成像结构病变的影响（ TORTUGA 试验）。
Rheumatology (Oxford). 2022 May 5;61(5):2063-2071. doi: 10.1093/rheumatology/keab543.
5
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.乌帕替尼治疗活动性强直性脊柱炎患者的疗效和安全性（SELECT-AXIS 1）：一项多中心、随机、双盲、安慰剂对照、2/3 期临床试验。
Lancet. 2019 Dec 7;394(10214):2108-2117. doi: 10.1016/S0140-6736(19)32534-6. Epub 2019 Nov 12.
6
The role of imaging in the diagnosis and management of axial spondyloarthritis.影像学在中轴型脊柱关节炎的诊断和管理中的作用。
Nat Rev Rheumatol. 2019 Nov;15(11):657-672. doi: 10.1038/s41584-019-0309-4. Epub 2019 Oct 7.
7
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group.磁共振成像（MRI）在脊柱关节炎患者骶髂关节病变中的应用：定义的更新和评估以及 ASAS MRI 工作组的验证。
Ann Rheum Dis. 2019 Nov;78(11):1550-1558. doi: 10.1136/annrheumdis-2019-215589. Epub 2019 Aug 17.
8
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.培塞丽珠单抗治疗非放射性中轴型脊柱关节炎的 52 周、随机、安慰剂对照试验。
Arthritis Rheumatol. 2019 Jul;71(7):1101-1111. doi: 10.1002/art.40866. Epub 2019 May 28.
9
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.选择性 Janus 激酶 1 抑制剂 filgotinib 治疗活动性强直性脊柱炎患者的疗效和安全性（TORTUGA）：一项随机、安慰剂对照、2 期临床试验的结果。
Lancet. 2018 Dec 1;392(10162):2378-2387. doi: 10.1016/S0140-6736(18)32463-2. Epub 2018 Oct 22.
10
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.依奇珠单抗，一种白细胞介素-17A 拮抗剂，用于治疗先前未接受生物疾病修饰抗风湿药物（COAST-V）治疗的强直性脊柱炎或放射学中轴型脊柱关节炎患者：一项 3 期随机、双盲、活性对照和安慰剂对照试验的 16 周结果。
Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22.